~~U.S.~~SECURITIES ~~Securities~~AND ~~and~~EXCHANGE ~~Exchange Commission~~COMMISSION

WASHINGTON, D.C. 20549

Washington, D.C. 20549

____________________

FORM 8-K

____________________

CURRENT REPORT

Pursuant to Section 13 or 15(d) ~~of the Securities Exchange Act of 1934~~

~~DATE OF~~of ~~REPORT (DATE OF EARLIEST EVENT REPORTED) February 17, 2009~~the

~~____________________~~Securities Exchange Act of 1934

~~Commission~~Date ~~File~~of ~~No.~~Report ~~0-25474~~(Date of earliest event reported): April 3, 2009

____________________

MEDCOM USA, INCORPORATED

(Exact name of ~~small~~registrant ~~business issuer~~ as specified in its charter)

Delaware	65-0287558
(State or other jurisdiction of	(IRS Employer Identification No.)
incorporation or organization)

Delaware

~~PO Box~~(State ~~90358~~or other jurisdiction of incorporation)

Henderson, NV 89009

0-25474		65-0287558
(Commission File Number)		(I.R.S. Employer
		Identification No.)

(Address of principal executive offices)

PO Box 90358, Henderson, NV	89009
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (877) 763-3729

~~(Issuer’s~~7975 North Scottsdale Rd., Suite D333, Scottsdale, ~~telephone~~AZ 85253 ~~number)~~

~~7975 N.~~(Former ~~Hayden~~name ~~Rd.,~~or ~~D333,~~former ~~Scottsdale~~address, ~~AZ 85253~~if changed since last report)

(Former name or address, if changed since last report)

Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

o ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 ~~CFR240~~CFR 240.13e-4(c))

Item 5 4.02 ~~Departure~~Non-Reliance ofon ~~Directors~~Previously orIssued ~~Certain~~Financial ~~Officers;~~Statements ~~Election~~or ~~of Directors; Appointment~~a ofRelated ~~Certain~~Audit ~~Officers;~~Report ~~Compensatory~~or ~~Arrangements~~Completed ~~of Certain~~Interim ~~Officers~~Review.

OnThe ~~February~~Company 14appointed new officers and directors on January 20, 2009, ~~the~~and ~~Board~~has commenced an investigation of ~~Directors~~issues ~~accepted~~that ~~the~~include, ~~resignation~~but ofmay ~~both~~not ~~David Breslow~~be ~~and~~limited ~~Mark~~to, possible ~~Goldfinger.~~discrepancies ~~There~~in ~~were~~the noamount ~~disagreements~~of ~~with~~the ~~David~~Company’s ~~Breslow~~reported orcurrent ~~Mark~~liabilities, ~~Goldfinger~~possible onissues ~~any~~underlying ~~matter~~the recording of ~~accounting~~revenue, ~~principles~~in oraddition ~~practices,~~to ~~financial statement~~other ~~disclosure~~issues ~~or auditing scope~~regarding orthe ~~procedure~~Company’s business and operations, and the actions of former management.

~~The~~We ~~Board~~have ofconsulted ~~Directors~~our ~~named~~outside ~~Robert~~SEC ~~Kite~~Counsel, asour ~~the~~independent ~~Chairman~~auditors, ofJewett ~~the~~Schwartz, Wolfe ~~Board~~and ~~leaving~~Associates, ~~two~~and ~~current~~prior independent auditor S. E. Clark and Company, ~~members~~P.C., and we have retained outside independent counsel to assist us in further investigation of other matters that effect our 1934 Act presentation and financial statement presentation for periods 2005-2008. Our professionals noted above have recommended to the Board of Directors of MedCom to file an 8K filing for non reliance for Item 4.02 for those years and have recommended that the Company re-audit and restate those years’ audits.

~~Effective February~~For 19the record, ~~2009,~~William ~~the~~P. ~~Company~~Williams was never appointed ~~Pamela~~or ~~Thompson~~elected asto the ~~company’s~~Board ~~Chief~~of ~~Financial~~Directors ~~Officer,~~in ~~Secretary,~~accordance with Delaware law and ~~Treasurer~~further MedCom never filed an 8K filing declaring his appointment. MsIn essence, Mr. ~~Thompson’s~~Williams was the ~~appointment~~defacto issole aboard ~~result~~member of the ~~company’s~~Company ~~removal~~as ofthe ~~William~~Company P.has ~~Williams~~not onhad a ~~January~~shareholder 23meeting since March 6, ~~2009~~2001.

~~Ms.~~During ~~Thompson~~the ~~holds~~period ~~a Bachelor~~ of ~~Science~~fiscal ~~from~~years ~~Minnesota~~ending ~~State~~2003 ~~University~~– -January ~~Moorhead in~~20, ~~Accountancy~~2009 ~~and~~at ~~holds~~all ~~her~~times ~~licenses as a Certified Public Accountant in~~ the ~~State~~Company ofwas ~~Arizona. She~~managed isby aWilliam ~~member~~P. ~~of the Arizona Society of Certified Public Accountants and American Institute of Certified Public Accountants~~Williams, ~~and is~~defacto ~~the~~Sole ~~founder~~Director and ~~principle Executive~~ Officer ~~of Pamela J. Thompson CPA~~, ~~P.C. She~~his iswife, ~~also~~Eva aWilliams, ~~member~~Secretary ofand ~~the Arizona Society of Certified Public Accountants~~Treasurer, and ~~Multiple~~Michael ~~Joys~~Malet, ~~Inc~~Executive Vice President.

~~Pamela Thompson has been an independent~~During ~~CPA since 1993. Prior to 1993, Ms. Thompson practiced public accounting for~~ the ~~international~~ ~~firm~~period of ~~Arthur~~fiscal ~~Andersen~~years ~~and~~ending ~~Pannell~~2006 ~~Kerr Forester,~~ and ~~a regional firm Eide~~2007, ~~Bailey~~William ~~and~~Bednarski ~~Company. Ms.~~was ~~Thompson has been~~Chief ~~featured~~Operating in Wall Street Journal, Arizona Republic, New Jersey Star, Arizona Women’s Success Magazine, National Basketball Players Association Magazine, Behind the Bench: National Basketball Wives Association MagazineOfficer.

InMr. ~~connection~~Williams ~~with~~appointed ~~this~~on ~~appointment~~September ~~the~~3, ~~Company~~2008 ~~entered~~four ~~into~~new aboard ~~three-year employment agreement with Ms. Thompson. The agreement provides for a base salary of $150~~members,~~000~~ ~~with~~Michael ~~bonus features she will participate in the Company’s health~~Malet, ~~disability~~Mark ~~and dental benefits~~Goldfinger, ~~insurance~~Robert ~~programs~~Kite, ~~pension~~ and ~~retirement plans,~~David ~~and~~Breslow ~~all other employee benefit and compensation arrangements available~~ to ~~other~~ ~~senior~~the ~~officers~~Board of ~~the~~Directors ~~Company. Ms. Thompson also received 1,000,000~~and ~~shares~~again ofthese ~~common~~board ~~stock~~members ofwere ~~the~~appointed ~~Company~~in ~~for~~accordance ~~being~~with aDelaware ~~Whistle~~law ~~Blower. The Company~~to ~~will also reimburse Ms. Thompson for all business expenses incurred~~fill ~~by her~~vacancies, inalthough ~~connection~~MedCom ~~with her~~never ~~employment~~filed ~~with~~ the ~~Company. The~~ ~~agreement~~required ~~also~~8K ~~provides~~filing ~~certain~~appointing ~~severance~~the ~~provisions in~~new ~~the~~board ~~event Ms~~members. The ~~Thompson’s~~Company ~~employment~~did isfile ~~terminated as~~ a ~~result~~press release of ~~her~~ ~~death, disability,~~this ~~or for Cause (as defined in the agreement)~~material matter.

InMr. ~~addition~~Williams toappointed ~~the above, in connection with the appointment of~~ Michael De La Garza ~~the~~ ~~Chief~~as ~~Executive Officer and~~ President ~~the~~ ~~Company~~on ~~entered~~September ~~into~~21, ~~a three-year~~2008 ~~employment~~and ~~agreement with Mr. De La Garza. The agreement provides for~~in aaccordance ~~base salary of $250,000~~ with ~~bonus features he will participate in~~ the ~~Company’s~~ ~~health,~~By-Laws ~~disability and dental benefits, insurance programs, pension and retirement plans, and all other employee benefit and compensation arrangements available to other senior officers~~ of ~~the~~MedCom ~~Company.~~ Mr. De La Garza is also ~~received 1,000,000 shares of common stock of~~ the ~~Company for being a~~Chief ~~Whistle~~Executive ~~Blower~~Officer. ~~The~~This ~~Company~~appointment ~~will~~of ~~also reimburse~~ Mr. De La Garza ~~for all~~was ~~business~~done ~~expenses incurred by him~~ in accordance ~~connection~~ with ~~his~~Delaware ~~employment~~law ~~with~~and ~~the Company. The~~MedCom ~~agreement~~did ~~also~~not ~~provides~~file ~~certain severance provisions in the event Mr. De La Garza’s employment is terminated as~~ a ~~result~~required of8K ~~his~~but ~~death,~~the ~~disability,~~Company ordid ~~for~~file ~~Cause~~a ~~(as~~press ~~defined~~release inof ~~the~~this ~~agreement)~~material matter.

On January 20, 2008 Michael Malet resigned as a member of the Board of Directors and the Board appointed Michael De La Garza as a Director and Robert Kite as Chairman. The Board of Directors removed Mr. Williams as a Board member. Since Mr. Williams was never ratified as a Board member under Delaware law his removal was administrative. The appointments of Mr. De La Garza and Mr. Kite were done in accordance with Delaware law and an 8K was filed for this material event.

On February 6, 2008 Pamela Thompson was appointed as Chief Financial Officer and Mark Goldfinger and David Breslow resigned from the Board of Directors at the completion of the Board meeting that day.

MedCom now has two board members, Mr. De La Garza and Mr. Kite. Mr. Kite is fully aware that securities counsel and current and prior independent auditors have recommended the 8K filing pursuant to Item 4.02 but, Mr. Kite refused to approve the filing of the 8K non reliance 4.02 and has actually threatened current management with retaliation if current management attempted to file this requested 8K. However, current management received another Comment Letter dated April 3, 2009 where the SEC gave management guidance and referenced “4.02(b) which mandates similar disclosures if you are advised by, or received notice from, your independent accountant that disclosure should be made or action should be taken to prevent future reliance on previously issued report or completed interim review.”

The Company believes that that there is a material difference between previously reported filings and the results of the internal investigation disclosed below. Through the internal investigation, certain issues gave rise as to the determination that there may be non-reliance on previously issued financial statements and related 1934 act filings. Included is such issues are the following:

FINANCIAL STATEMENTS DISCREPANCIES:

It is a distinct probability that prior management and sales personnel would forge signatures of Doctors to licensing agreements and even fabricated the names of hospitals;

It is a possibility that prior management would finance licensing agreements with the Company’s financing company for software that was never installed. Prior management did certify that all units were actually installed, when it apparently did not occur;

It is a probability that prior management would finance licensing agreements for 48 month terms when in fact the actual term of the license agreements were for12 months. In addition, it is possible that revenues arising from these license agreements were inflated. We have not fully calculated the material difference in revenue from these acts, but current management believes that it is substantial;

It is probable that prior management shredded invoices from vendors and documents to conceal the true debt of the Company. Our investigation has found total accounts payables and accrued liabilities of $1,395,603. In contrast, the reported payables in public filings, certified by prior management for the Company was $128,060, which is a difference of $1,267,513;

SECURITIES EXCHANGE OF 1934 ACT DISCREPANCIES:

Prior management in fiscal year ended June 30, 2005 reported officer salary of $450,000 for Mr. Williams when Mr. Williams’ compensation, when considering personal reimbursements and payments, was at least $831,322.79, which is a material difference of $381,322.79;

Prior management in fiscal year ended June 30, 2006 reported officer salary of $450,000 of Mr. Williams when Mr. Williams’ compensation, when considering personal reimbursements and payments, was at least $709,258.97 which is a material difference of $259,258.97;

Prior management in fiscal year ended June 30, 2007 reported officer salary of $450,000 of Mr. Williams when Mr. Williams’ compensation, when considering personal reimbursements and payments, was at least $732,641.08 which is a material difference of $282,641.08;

Prior management in fiscal year ended June 30, 2008 reported officer salary of $450,000 of Mr. Williams when Mr. Williams’ compensation, when considering personal reimbursements and payments was at least $723,451.45 which is a material difference of $273,451.45. We have not fully investigated the accounting treatment of the additional compensation of Mr. Williams; and

It is possible that that prior management issued common stock for no consideration at all. We have not completed our full investigation of the many issuances of common stock to Mr. Williams and Mr. Malet and to related parties and affiliates.

As a result of the above and related significant uncertainties, the approval of a Board of Director, together with the current management of the Company and with a discussion with our independent auditors, independent SEC counsel, outside independent counsel, and our prior independent auditors we have determined that the Company’s previously issued fiscal years ended 2005 - 2008 financial statements should not be relied upon and may be inaccurate at this time.

The Company is still investigating the actions of prior management and may discover additional information as well as conclude that financial statements of other prior periods may also need to be restated. The Company will update its findings as they become available.

The Company is currently cooperating with governmental authorities and will continue to do so.

Litigation that was filed in the United States District Court for the District of Arizona, Case No. 2009cv00298, by MedCom and Card Activation Technologies, Inc. against William P. Williams, his wife Eva Williams, Michael Malet, his wife Annette Malet, and various affiliated entities for securities fraud, racketeering, and other state law causes of actions, seeking recovery of more than ten million dollars ($10,000,000). A copy of the Complaint is attached hereto as Exhibit 9.01.

The management of the Company has discussed the matters reported in this Item 4.02 with the Company’s independent accountants and securities counsel.

Item 99.01 Other matters

Prior management engaged a firm named Source Capital Group, Inc. for the years starting in 2003 through January 20, 2008. This firm provided an analyst’s report for both MedCom USA, Inc, and Card Activation Technologies, Inc. Current management has reviewed the report and the projected expectation of revenue for both companies and determined it to be misrepresented. Therefore, we have removed that analyst report from the Company’s website as a consequence of determining that the report never reflected accurately the projected results of both companies and cannot be relied upon.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

~~None~~9.01 MedCom et.al. v. Williams et.al.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned ~~hereunto~~thereunto duly authorized.

	MedCom USA Incorporated
	MEDCOM USA INCORPORATED
Date: February 20, 2009	By:	/s/ Michael De La Garza
Date: April 3, 2009	/s/ Michael De La Garza
		Michael De La Garza President Chief Executive Officer (Principle Executive Officer)
	Michael De La Garza
	Chief Executive Officer, President, Director

	MedCom USA Incorporated
Date: February 20, 2009	By:	/s/ Pamela Thompson
		Pamela Thompson Chief Financial Officer (Principle Financial Officer)

Filing Compare · MEDCOM USA INC